Tirzepatide Rx Only
Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to support advanced metabolic and weight management goals. Unlike traditional GLP-1 therapies alone, tirzepatide targets both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 pathways to provide broader metabolic support
Potential Benefits
Potential benefits associated with Tirzepatide therapy may include:
Significant appetite reduction
Weight management support
Improved insulin sensitivity
Reduced food cravings
Metabolic optimization
Cardiometabolic wellness support
Body composition improvement
Monthly, 3-mo, and 6-mo plans
Starting price applies to 3-mo plan
US-licensed pharmacies
Pause or cancel anytime
Starting at $299
Free, discreet shipping
Ongoing Support
Subscribe & Save
Prescription medications require an online evaluation by a licensed medical professional. Compounded products are prepared by licensed U.S. pharmacies and are not reviewed or approved by the FDA. Packaging may differ from images shown.
$299/month
Applies to 1st month of 3 month plan
What’s included
Personalized, clinician-guided plan
Monthly, 3-month, and 6-month plans
Dispensed by US-licensed compounding pharmacy
Unlimited protocol adjustments and messaging
Ongoing support and check-ins
Pause or cancel anytime
What is Tirzepatide?
(tir-ZEP-uh-tide)
Tirzepatide is a synthetic 39-amino acid peptide that simultaneously activates both GIP and GLP-1 receptors, the two key incretin hormones regulating postprandial insulin secretion, appetite, and energy balance. This dual mechanism distinguishes it from earlier GLP-1 receptor agonists such as semaglutide and liraglutide, which target only the GLP-1 receptor.